Press Release
Category Added in a WPeMatico Campaign
-
Steve Wozniak Surprisingly Appears at DREAME NEXT: Dreame Unveils Two Smartphones with 10+ Industry Breakthroughs
SAN FRANCISCO, April 29, 2026 /PRNewswire/ — Dreame Technology today officially launched two smartphones at the Connect Next segment of DREAME…
Read More » -
CBS ArcSafe® RSK-CSH-W Chicken Switch Hitter Remote Switching Kit Wins Specialty Products Category in EC&M’s Product of the Year Awards
DENTON, Texas, April 29, 2026 /PRNewswire/ — CBS ArcSafe, a leading manufacturer of remote racking and switching solutions for low-…
Read More » -
“The Flash” Dwyane Wade Joins Dreame Next in Silicon Valley as Dreame Wet Dry Vacuum Showcases New Products and Latest Technologies
SAN FRANCISCO, April 29, 2026 /PRNewswire/ — On April 28, Dreame Wet Dry Vacuum hosted its “Dreame Next” global launch…
Read More » -
Ascletis to Present Data on Multiple Programs at the American Diabetes Association’s 2026 Scientific Sessions
HONG KONG, April 29, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today poster presentations highlighting multiple programs…
Read More » -
BuildSubmarines.com and RFK Racing Bring Hands-On STEM Learning to the Talladega Fan Zone
TALLADEGA, Ala., April 29, 2026 /PRNewswire/ — BuildSubmarines.com, in collaboration with RFK Racing and the Talladega No. 60 car, is bringing…
Read More » -
Dreame Technology’s “DREAME NEXT” Smart Wearables: Smart Ring Comes Under the Spotlight
SAN FRANCISCO, April 29, 2026 /PRNewswire/ — Dreame Technology, a global leader in smart home appliances and health technology, today…
Read More » -
Market Defense Expands Capabilities with Acquisition of Knoza by Parent Company D2E Labs
SEATTLE, April 29, 2026 /PRNewswire/ — Market Defense today announced its expansion through the acquisition of Knoza by its parent company,…
Read More » -
Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca
Option exercise triggers $25M payment to Pinetree. CAMBRIDGE, Mass., April 29, 2026 /PRNewswire/ — Pinetree Therapeutics, Inc. (“Pinetree”), a biotechnology…
Read More »